Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center
University of Nebraska
Ohio State University Comprehensive Cancer Center
University of Nebraska
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
Thomas Jefferson University
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Alliance for Clinical Trials in Oncology
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
University of Texas Southwestern Medical Center
Barbara Ann Karmanos Cancer Institute
Wake Forest University Health Sciences
University of Southern California
Masonic Cancer Center, University of Minnesota
Eastern Cooperative Oncology Group
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Massachusetts General Hospital
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Alliance for Clinical Trials in Oncology
Yale University
Rutgers, The State University of New Jersey
Fred Hutchinson Cancer Center
City of Hope Medical Center
SWOG Cancer Research Network
Mesoblast, Ltd.
City of Hope Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Northside Hospital, Inc.
National Cancer Institute (NCI)
Roswell Park Cancer Institute
National Cancer Institute (NCI)
University of California, San Francisco
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center